FCM
PTLA
Farallon Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,844,757
| Closed | -$33.2M | – | 144 |
|
|
2020
Q2 | $33.2M | Buy |
+1,844,757
| New | +$33.2M | 0.27% | 69 |
|
|
2017
Q3 | – | Sell |
-855,000
| Closed | -$48M | – | 96 |
|
|
2017
Q2 | $48M | Buy |
855,000
+470,000
| +122% | +$26.4M | 0.5% | 37 |
|
|
2017
Q1 | $15.1M | Buy |
385,000
+285,000
| +285% | +$11.2M | 0.17% | 56 |
|
|
2016
Q4 | $2.24M | Buy |
+100,000
| New | +$2.24M | 0.03% | 67 |
|